728 x 90

Revolutionary Biocomposite STIMULAN Takes Argentina and Taiwan by Storm, Transforming Medical Treatments

Revolutionary Biocomposite STIMULAN Takes Argentina and Taiwan by Storm, Transforming Medical Treatments

Biocomposites, an international medical devices company, has recently announced that STIMULAN, their antibiotic carrier, has been approved for use in bone and soft tissue in Argentina and Taiwan. This approval expands the list of territories where STIMULAN is available, which already includes the UK, EU, Canada, Saudi Arabia, Mexico, and South Africa.

The approval of STIMULAN in Argentina and Taiwan is a significant development in the field of infection management in bone and soft tissue. This innovative product offers surgeons the flexibility to use a wide range of antibiotics to treat infections, reducing the risk of reinfection and improving patient outcomes.

Biocomposites’ STIMULAN Rapid Cure and STIMULAN Kit products are the first and only calcium matrices that can carry antibiotics into bone and soft tissue. This unique feature allows surgeons to deliver antibiotics directly to the affected area at concentration levels that cannot be achieved through systemic administration.

By lowering rates of reinfection and decreasing hospital readmissions, STIMULAN has already been used in over 80,000 cases every year, making a significant impact on patient care worldwide.

Michael Harris, the CEO of Biocomposites, emphasizes that STIMULAN is the leading calcium matrix for carrying antibiotics and the only one approved for use in bone and soft tissue. With the addition of Argentina and Taiwan to the list of approved territories, more surgeons will have the ability to tailor their infection treatment plans and transform patients’ lives.

This expansion of STIMULAN’s availability highlights the growing importance of innovative solutions in infection management. By providing surgeons with a tool that allows for targeted and effective treatment, STIMULAN not only improves patient outcomes but also contributes to the overall reduction of antibiotic resistance.

As the global healthcare industry continues to prioritize sustainable and environmentally friendly practices, the approval of STIMULAN in Argentina and Taiwan aligns with the goals of EcoReporter. By promoting the use of biocomposites and advanced medical technologies, we can contribute to a healthier and more sustainable future for all.

Avatar of Akash Osta
Akash Osta
CONTRIBUTOR
PROFILE